Amgen (AMGN) Financials

$437.23

$-6.89 (-1.55%)

As on 04-Sep-2026 19:59EDT

Market cap

$236,381 Mln

Revenue (TTM)

$38,125 Mln

P/E Ratio

27.6

P/B Ratio

20.5

Div. Yield

2.2 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	38,125.00	36,741.00	33,424.00	28,190.00	26,323.00	25,979.00
Cost of Revenue	10,427.00	10,729.00	12,858.00	8,451.00	6,406.00	6,454.00
Gross Profit	27,698.00	26,012.00	20,566.00	19,739.00	19,917.00	19,525.00
Operating Expenses	15,050.00	15,336.00	13,308.00	11,842.00	10,351.00	11,886.00
Operating Profit (EBIT)	12,648.00	10,676.00	7,258.00	7,897.00	9,566.00	7,639.00
Other Income	--	--	--	--	-814.00	259.00
Profit before Tax	10,287.00	8,976.00	4,609.00	7,855.00	7,346.00	6,701.00
Provision for Tax	1,544.00	1,265.00	519.00	1,138.00	794.00	808.00
Profit after Tax (Net Income)	8,743.00	7,711.00	4,090.00	6,717.00	6,552.00	5,893.00
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	6,552.00	5,893.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	11,688.00	8,658.00	5,877.00	6,232.00	3,661.00	6,700.00
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	58,449.00	56,439.00	62,863.00	72,530.00	45,773.00	42,281.00
Current Liabilities	25,502.00	25,489.00	23,099.00	18,392.00	15,687.00	12,184.00
Total Liabilities	121,141.00	90,586.00	91,839.00	97,154.00	65,121.00	61,165.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	60,678.00	61,529.00	62,809.00	66,822.00	42,935.00	41,780.00
Current Assets	34,961.00	29,057.00	29,030.00	30,332.00	22,186.00	19,385.00
Total Assets	121,141.00	90,586.00	91,839.00	97,154.00	65,121.00	61,165.00
Total Debt*	57,304.00	54,604.00	60,099.00	64,613.00	38,945.00	33,309.00
Net Current Assets	9,459.00	3,568.00	5,931.00	11,940.00	6,499.00	7,201.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	9,958.00	11,490.00	8,471.00	9,721.00	9,261.00
Cash Flow from Investing Activities	--	-1,943.00	-1,046.00	-26,204.00	-6,044.00	733.00
Cash from Financing Activities	--	-10,859.00	-9,415.00	21,048.00	-4,037.00	-8,271.00
Net Cash Inflow / Outflow	--	--	--	--	-360.00	1,723.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	16.10	14.20	7.55	12.44	12.16	10.43
Cash EPS ($)	--	23.72	17.86	19.11	18.50	16.44
Adjusted Book Value ($)	--	15.94	10.84	11.54	6.79	11.86
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	18.34	21.20	15.69	18.04	16.39
Free Cash Flow per Share ($)	--	14.92	19.18	13.63	16.30	14.83

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	11.93	5.98	11.84	15.86	14.30
ROE (%)	85.94	106.10	67.55	135.79	126.47	73.16
ROA (%)	7.62	8.45	4.33	8.28	10.38	9.50
EBIT Margin (%)	24.95	31.93	23.23	28.01	33.25	30.40
Net Margin (%)	22.93	20.99	12.24	23.83	25.69	22.46
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	9.23	0.10	0.19	0.07	0.01	0.02
EBIT Growth (%)	-8.33	51.09	-1.68	-9.77	10.81	-15.93
Net Profit Growth (%)	32.09	88.53	-39.11	2.52	11.18	-18.87
EPS Growth (%)	31.70	0.88	-0.39	0.02	0.17	-0.16
Book Value Growth (%)	56.48	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	27.55	23.05	34.54	23.15	21.61	21.57
Price / Book Value	20.48	20.53	24.04	24.96	38.67	18.97
Dividend Yield (%)	2.21	--	--	--	--	--
EV/EBITDA	16.04	13.21	14.18	25.11	14.07	13.49
Close Price ($)	362.12	327.31	260.64	288.02	262.64	224.97
High Price ($)	391.29	346.38	346.85	289.04	296.67	276.69
Low Price ($)	269.77	257.05	253.30	211.71	214.39	198.64
Market Cap ($ Cr)	236,380.54	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	4.44	6.31	10.23	10.37	10.64	4.97
Short term debt to equity ratio	0.47	0.53	0.60	0.23	0.43	0.01
Current Ratio	1.37	1.14	1.26	1.65	1.41	1.59
Quick Ratio	1.13	0.90	0.95	1.13	1.10	1.26
Interest Coverage	4.86	4.26	2.46	2.75	6.22	6.60

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	26.82	26.05	22.44	28.17	24.28	22.48
Asset Turnover	0.33	0.40	0.35	0.35	0.42	0.42
Receivable days	--	84.85	84.38	92.86	84.86	72.86
Inventory Days	--	225.08	234.58	312.22	257.03	225.78
Payable days	--	72.77	49.68	68.33	83.76	78.86
Cash Conversion Cycle	--	237.16	269.28	336.75	258.13	219.77

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)